Emerging from Covid-19: What next for the pharmaceutical industry?

Only members can access this event recording.
Please login to view this member's-only event.
General information

This On Demand Shared Experience shares insights from a new survey by Grayling, presented by Head of Health, Kathryn Ager. Kathryn then moderates an interesting panel discussion about what next for the pharma industry.  Panel includes:

  • Dr Helen Rippon, CEO, Worldwide Cancer Research
  • David Flynn, Corporate Communications Lead, Roche
  • Fanny van der Loo, Public Affairs Manager EMEA, Edwards Lifesciences
  • Jennie Younger, Executive Director of Development and Alumni Relations, King's College London


Emerging from Covid-19: What next for the pharmaceutical industry?

43 min